On June 4th, BioPortUSA CEO Mark Lesselroth had the honor to kick off the Global Innovation hub series at BIO in Philadelphia. As a result of this presentation, both Enterprise Singapore and Enterprise Spain reached out to BioPort to enquire how the company could be of service to life science organizations in those respective countries wishing to expand their operations into the United States. [...]
In May 2019, Mark Lesselroth, CEO of BioPortUSA and David Reed, Principal of Reed Business law, had an opportunity to join Jon Wilks our partner at UK HealthGateway to discuss the topic of Brexit and how it could impact US market entry for UK based medtech firms. [...]
Join Mark Lesselroth, CEO of BioPortUSA on June 4th at 1:30pm in theatre A at BIO in Philadelphia, as he kicks off the Global Innovation Hub series - https://bio2019.zerista.com/profile/member/2027233 highlighting why the US is an ideal market for international Biotech firms to invest in.[...]
Mark Lesselroth, CEO of BioPortUSA along with Manfred Kauer, Senior Consultant of BioPortUSA for the D-A-CH region will be attending Bionnale 2019, the largest networking event for life sciences and healthcare industries in Germany.[...]
BioPortUSA announced a new partnership today with BEO Berlin, one of Germany’s leading regulatory consulting firms for the medical device industry. “Having access to BEO Berlin will allow us to better support our US clients in the med-tech field who are interested in expanding into the German market.[...]
Manfred Kauer, Senior Consultant for BioPortUSA’s European office will be attending the annual Biotech Conference April 9, 2019 in Würzburg, Germany https://www.biotechnologietage.de/en/. This event is co-organized by BIO Deutschland and the Council of German Bioregions. [...]
Mark Lesselroth, CEO of BioPortUSA will speak at the BIO International Convention (https://convention.bio.org/2019/) June 3-6 in Philadelphia, PA. on the subject of “Demystifying Market Entry into the USA” The focus of this presentation will be on providing an overview of what it takes for an international life science company to effectively enter the US market and accelerate the commercialization of their product lines. We will touch on the importances of determining early investment, IP Landscape, Regulatory Pathway, and the importance of Market Access. The latter is perhaps the most critical as it is an area that most international companies have little experience with but will need to understand if they are going to achieve success in the USA.[...]
BioPortUSA is excited to announce the expansion of its International Alliance Partner Network with the addition of UK Health Gateway. The company is lead by Jon Wilks and Roy Lilley, and provides an expert team who are familiar with regulatory affairs, quality system management, primary and secondary care development, reimbursement and distribution for the UK marketplace. [...]
Social Media
